Teva Pharmaceutical Industries Ltd. (TEVA) and Procter & Gamble Co. (PG) agreed to combine their consumer-health businesses outside North America in a joint venture that aims to capture more of the $200 billion market for over-the-counter medicines.
Read the full story
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.